Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TRIM58 inactivates p53/p21 to promote chemoresistance via ubiquitination of DDX3 in breast cancer
Juan Wang, Fan Yang, Jialang Zhuang, et al.
The International Journal of Biochemistry & Cell Biology (2021) Vol. 143, pp. 106140-106140
Closed Access | Times Cited: 20

Showing 20 citing articles:

TRIM family contribute to tumorigenesis, cancer development, and drug resistance
Ning Huang, Xiaolin Sun, Peng Li, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 86
Discovery of Ligands for TRIM58, a Novel Tissue-Selective E3 Ligase
Klemens Hoegenauer, Shaojian An, Jake Axford, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 12, pp. 1631-1639
Closed Access | Times Cited: 16
Long noncoding RNA ST8SIA6‐AS1 promotes cell proliferation and metastasis in triple‐negative breast cancer by targeting miR‐145‐5p/CDCA3 to inactivate the p53/p21 signaling pathway
Yan Qiao, Bin Wang, Yu Yan, et al.
Environmental Toxicology (2022) Vol. 37, Iss. 10, pp. 2398-2411
Closed Access | Times Cited: 19
Cyperotundone combined with adriamycin induces apoptosis in MCF-7 and MCF-7/ADR cancer cells by ROS generation and NRF2/ARE signaling pathway
Wenna Shao, Xinzhao Wang, Zhaoyun Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
NR4A1 depletion inhibits colorectal cancer progression by promoting necroptosis via the RIG-I-like receptor pathway
Jinghan Zhu, Juntao Li, Kexi Yang, et al.
Cancer Letters (2024) Vol. 585, pp. 216693-216693
Closed Access | Times Cited: 3
The roles and targeting options of TRIM family proteins in tumor
Yuxin Zhang, Wenzhou Zhang, Lufeng Zheng, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
ITPR1-AS1 promotes small cell lung cancer metastasis by facilitating P21 splicing and stabilizing DDX3X to activate the cRaf-MEK-ERK cascade
Quanli Zhang, Limin Zheng, Yongkang Bai, et al.
Cancer Letters (2023) Vol. 577, pp. 216426-216426
Open Access | Times Cited: 8
Constructing a Prognostic Model of Uterine Corpus Endometrial Carcinoma and Predicting Drug-Sensitivity Responses Using Programmed Cell Death-Related Pathways
Jingwen Meng, Chen Zong, Meixia Wang, et al.
Journal of Cancer (2024) Vol. 15, Iss. 10, pp. 2948-2959
Open Access | Times Cited: 2
TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells
Xujun Li, Jing Jiang, Qian Wu, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 8, pp. 1186-1200
Open Access | Times Cited: 2
TRIM proteins in breast cancer: Function and mechanism
Xin De Bai, Jianming Tang
Biochemical and Biophysical Research Communications (2022) Vol. 640, pp. 26-31
Closed Access | Times Cited: 10
Dihydroartemisinin synergistically enhances the cytotoxic effects of oxaliplatin in colon cancer by targeting the PHB2‐RCHY1 mediated signaling pathway
Xiwei Wang, Yingying Zheng, Zhengbin Chai, et al.
Molecular Carcinogenesis (2022) Vol. 62, Iss. 3, pp. 293-302
Closed Access | Times Cited: 8
E3 ubiquitin ligase-dependent regulatory mechanism of TRIM family in carcinogenesis
Gui Zhang, Yunfang Zhang, Luxuan Chen, et al.
Cancer Insight (2023) Vol. 2, Iss. 1, pp. 37-48
Closed Access | Times Cited: 4
Emerging roles of tripartite motif family proteins (TRIMs) in breast cancer
Jianing Cao, Mengdi Yang, Duancheng Guo, et al.
Cancer Medicine (2024) Vol. 13, Iss. 14
Open Access | Times Cited: 1
E3 ubiquitin ligase-dependent regulatory mechanism of TRIM family in carcinogenesis
Gui Zhang, Yunfang Zhang, Luxuan Chen, et al.
Cancer Insight (2023)
Open Access | Times Cited: 2
TRIM58 functions as a tumor suppressor in colorectal cancer by promoting RECQL4 ubiquitination to inhibit the AKT signaling pathway
Naizhi Sun, Jiacheng Shen, Yuhua Shi, et al.
World Journal of Surgical Oncology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Comprehensive Analysis of the Expression and Prognosis for Tripartite Motif-Containing Genes in Breast Cancer
Lvwen Ning, Qin Huo, Ni Xie
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 3
Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy
Yi-Zi Zheng, Jiaying Li, Lvwen Ning, et al.
Breast Cancer Targets and Therapy (2022) Vol. Volume 14, pp. 475-487
Open Access | Times Cited: 3
Advances in the Understanding of the Pathogenesis of Triple‐Negative Breast Cancer
Yiwei Liu, Yuhan Zou, Yangli Ye, et al.
Cancer Medicine (2024) Vol. 13, Iss. 22
Open Access
Redirecting E3 Ubiquitin Ligases for Targeted Protein Degradation with Heterologous Recognition Domains
Huan Yang, Ge Zheng, Grace Y. Li, et al.
Journal of Biological Chemistry (2024), pp. 108077-108077
Open Access
Knockdown of PRKD2 Enhances Chemotherapy Sensitivity in Cervical Cancer via the TP53/CDKN1A Pathway
Zheng Hu, Ji Ma, Danni Gong, et al.
Current Cancer Drug Targets (2022) Vol. 23, Iss. 2, pp. 159-170
Closed Access | Times Cited: 1
Page 1

Scroll to top